Using an in vivo model with murine breast cancer 4T1 cell line, Zhou et al. [156] have shown that HSP70-targeting siRNA sensitized the tumor to the TNF-related apoptosis-inducing ligand (TRAIL) therapy. The gene discussed is HSPA1A; the disease is breast carcinoma.